POSEIDON PHARMACEUTICALS A/S: Financial statements 2014
CVR: 26133130
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
POSEIDON PHARMACEUTICALS A/S (CVR 26133130) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK 142,000 compared with DKK 140,000 the year before. Equity in the 2014 report amounted to DKK 63,822,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 142,000
- Equity
- DKK 63,822,000
- Total Assets
- DKK 63,837,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | 142 t. | 63.8 mio. | - |
| 2013 | - | - | 140 t. | 63.7 mio. | - |
| 2012 | - | - | 194 t. | 63.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
POSEIDON PHARMACEUTICALS A/S has published its annual report for 2013. The net result was DKK 140,000.
About POSEIDON PHARMACEUTICALS A/S
POSEIDON PHARMACEUTICALS A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2001. The company has been dissolved on 3 January 2017. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named THORAX ApS and KR 957 ApS. The company has 0 employees (2004). In 2015, the company reported a net result of DKK 143,000 compared with DKK 142,000 the year before. Equity in the 2015 report amounted to DKK 63,965,000.